Amy L. Burroughs - Chief Executive Officer, Director at Terns Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
TERN on Nasdaq
All Insider Reports
All Insider Reports

Amy L. Burroughs - trading volume in the past year for Terns Pharmaceuticals, Inc.

Holdings reported by Amy L. Burroughs for Terns Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 288,976 $10,843,997 $37.53 15 Jan 2026 Direct
Common Stock 8,319 $336,087 $40.40 14 Jan 2026 Trust
Stock Option (Right to Buy) 984,700 15 Jan 2026 Direct Common Stock
Restricted Stock Unit 0 05 Jan 2026 Direct Common Stock

Transactions reported by Amy L. Burroughs for Terns Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.